TTD | Drug: D0K3QL

Drug General Information
Drug ID	D0K3QL
Former ID	DNC003519
Drug Name	FR-230481
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526277]
Structure		Download 2D MOL 3D MOL
Formula	C30H39N3O4S
Canonical SMILES	COC1=CC2=C(CCCC2(CNCC3CCN(CC3)CCNS(=O)(=O)C4=CC=CC5=CC=<br />CC=C54)O)C=C1
InChI	1S/C30H39N3O4S/c1-37-26-12-11-25-8-5-15-30(34,28(25)20-26)22-31-21-23-13-17-33(18-14-23)19-16-32-38(35,36)29-10-4-7-24-6-2-3-9-27(24)29/h2-4,6-7,9-12,20,23,31-32,34H,5,8,13-19,21-22H2,1H3
InChIKey	HROMPGSHGXAFBQ-UHFFFAOYSA-N
PubChem Compound ID	10030142
Target and Pathway
Target(s)	Neuropeptide Y receptor 5	Target Info	Inhibitor	[526277]
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Peptide ligand-binding receptors
Reactome	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 526277	Bioorg Med Chem Lett. 2002 Mar 11;12(5):799-802.Novel potent antagonists of human neuropeptide Y Y5 receptors. Part 3: 7-methoxy-1-hydroxy-1-substituted tetraline derivatives.
Ref 526277	Bioorg Med Chem Lett. 2002 Mar 11;12(5):799-802.Novel potent antagonists of human neuropeptide Y Y5 receptors. Part 3: 7-methoxy-1-hydroxy-1-substituted tetraline derivatives.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information